Core evidence

Keyphrases

Publications

volume 15, 2020

volume 14, 2019

Matteo Bassetti, Nadia Castaldo, Alessia Carnelutti, Maddalena Peghin, Daniele Roberto Giacobbe
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy. Core evidence 14 (2019)
Maria Galkin, Brian A Jonas
Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy. Core evidence 14 (2019)
Adam D Taylor, Kenneth G Saag
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core evidence 14 (2019)
Kei Ishii, Nao Morii, Hiroyasu Yamashiro
Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy. Core evidence 14 (2019)
Rodrigo Alonso, Ada Cuevas, Pedro Mata
Lomitapide: a review of its clinical use, efficacy, and tolerability. Core evidence 14 (2019)

volume 13, 2018

Steven C Brousell, Joseph J Fantony, Megan G Van Noord, Michael R Harrison, Brant A Inman
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy. Core evidence 13 (2018)
Panteha Eshtiaghi, Melinda J Gooderham
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis. Core evidence 13 (2018)
Simona Lattanzi, Francesco Brigo, Claudia Cagnetti, Alberto Verrotti, Gaetano Zaccara, Mauro Silvestrini
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy. Core evidence 13 (2018)

volume 12, 2017

Mario V Beccari, Calvin J Meaney
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review. Core evidence 12 (2017)
Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy. Core evidence 12 (2017)

volume 11, 2016

Fernanda S Tonin, Astrid Wiens, Fernando Fernandez-Llimos, Roberto Pontarolo
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy. Core evidence 11 (2016)
George A Margaritopoulos, Eirini Vasarmidi, Katerina M Antoniou
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. Core evidence 11 (2016)
Sebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, Melissa Bersanelli
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy. Core evidence 11 (2016)
Emiliano Angeloni
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy. Core evidence 11 (2016)
Christine Serratrice, Sebastian Carballo, Jacques Serratrice, Jérome Stirnemann
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy. Core evidence 11 (2016)

volume 10, 2015

Tushar Acharya, Prakash Deedwania
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation. Core evidence 10 (2015)
Jennifer Dinnel, Bonny L Moore, Brent M Skiver, Prithviraj Bose
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy. Core evidence 10 (2015)
Joumana Kmeid, Zeina A Kanafani
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review. Core evidence 10 (2015)
Minoru Inomata, Yasuhiko Nishioka, Arata Azuma
Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis. Core evidence 10 (2015)
David J Hellerstein, Joseph Flaxer
Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy. Core evidence 10 (2015)
Krystal L Edwards, Molly G Minze
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes. Core evidence 10 (2015)
Luigi Celio, Monica Niger, Francesca Ricchini, Francesco Agustoni
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy. Core evidence 10 (2015)
Adam M Henrie, James J Nawarskas, Joe R Anderson
Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review. Core evidence 10 (2015)

volume 10, 2014

Julie N Graff, Erin D Chamberlain
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy. Core evidence 10 (2014)

volume 9, 2014

Susana Coimbra, Américo Figueiredo, Alice Santos-Silva
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis. Core evidence 9 (2014)
Cordula Koerner-Rettberg, Manfred Ballmann
Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. Core evidence 9 (2014)
Otávio Clark, Tobias Engel Ayer Botrel, Luciano Paladini, Mariana Bhering Andrade Ferreira
Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis. Core evidence 9 (2014)
Deepshikha Khanna, Subhash Bharti
Luliconazole for the treatment of fungal infections: an evidence-based review. Core evidence 9 (2014)
Mitchell S Buckley, Andrew J Berry, Nadine H Kazem, Shardool A Patel, Paul A Librodo
Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review. Core evidence 9 (2014)
Manuela Di Franco, Maria Chiara Gerardi, Bruno Lucchino, Fabrizio Conti
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis. Core evidence 9 (2014)
Su Jeong Song, William E Smiddy
Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential. Core evidence 9 (2014)
Ulka N Vaishampayan
Development of cabozantinib for the treatment of prostate cancer. Core evidence 9 (2014)
Sujan Ravi, Ashwani K Singal
Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer. Core evidence 9 (2014)
Pola de la Torre, Annette C Reboli
Micafungin: an evidence-based review of its place in therapy. Core evidence 9 (2014)
Philippe Lagacé-Wiens, Andrew Walkty, James A Karlowsky
Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections. Core evidence 9 (2014)

volume 8, 2013

Carolyn A Goard, Aaron D Schimmer
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies. Core evidence 8 (2013)
Brendan T Bowman, Mitchell H Rosner
Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremia. Core evidence 8 (2013)
Julio C Chavez, Eva Sahakian, Javier Pinilla-Ibarz
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia. Core evidence 8 (2013)
Tobias Engel Ayer Botrel, Luciano Paladini, Otávio Augusto C Clark
Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis. Core evidence 8 (2013)
Ali R Golshayan, Emmanuel S Antonarakis
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer. Core evidence 8 (2013)
Stefan Josef Schaller, Heidrun Fink
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core evidence 8 (2013)
Tobias Engel Ayer Botrel, Otávio Clark, Antônio Carlos Lima Pompeo, Francisco Flávio Horta Bretas, Marcus Vinicius Sadi, Ubirajara Ferreira, Rodolfo Borges Dos Reis
Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis. Core evidence 8 (2013)

volume 7, 2012

Noel Lee, Arnold Wald
Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation. Core evidence 7 (2012)
Ranjith Babu, D Cory Adamson
Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma. Core evidence 7 (2012)
Bernard Floccard, Etienne Hautin, Laurence Bouillet, Brigitte Coppere, Bernard Allaouchiche
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II. Core evidence 7 (2012)
Lawrence Kleinberg
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide. Core evidence 7 (2012)